Mitsubishi Tanabe Pharma Included in the Dow Jones Sustainability Asia Pacific Index（Sep. 18, 2019）

Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka; President & Representative Director: Masayuki Mitsuka) announced that it has been included for two consecutive years in the Dow Jones Sustainability Asia Pacific Index, the Asia Pacific subset of Dow Jones Sustainability Indices (DJSI).

DJSI are the representative ESG investment indices developed by Dow Jones of the U.S. and RobecoSAM of Switzerland and evaluate corporate sustainability from the three aspects of environmental, society and governance.

We will continue striving to realize a sustainable society by fulfilling corporate social responsibility in our business activities.

Attachments

  • Original document
  • Permalink

Disclaimer

Mitsubishi Tanabe Pharma Corporation published this content on 18 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 September 2019 01:21:07 UTC